Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-FR Version v4-FR
Language French French
Date Updated 2020-01-28 2020-01-04
Drug Identification Number 02471051 02471051
Brand name TARO-DIPYRIDAMOLE/ ASA TARO-DIPYRIDAMOLE/ ASA
Common or Proper name DIPYRIDAMOLE/ ASA DIPYRIDAMOLE/ ASA
Company Name TARO PHARMACEUTICALS INC TARO PHARMACEUTICALS INC
Ingredients ACETYLSALICYLIC ACID DIPYRIDAMOLE ACETYLSALICYLIC ACID DIPYRIDAMOLE
Strength(s) 25MG 200MG 25MG 200MG
Dosage form(s) CAPSULE (IMMEDIATE AND EXTENDED RELEASE) CAPSULE (IMMEDIATE AND EXTENDED RELEASE)
Route of administration ORAL ORAL
Packaging size 60 60
ATC code B01AC B01AC
ATC description ANTITHROMBOTIC AGENTS ANTITHROMBOTIC AGENTS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-11-22 2019-11-22
Estimated end date 2020-03-20 2020-02-28
Actual end date
Shortage status Actual shortage Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments